Learn about the latest research findings and advancements in lupus science that came out of the world’s premier rheumatology conference.
Mallinckrodt and the LFA Present Data from Survey of Over 1,500 Individuals with Self-Reported Lupus
Study finds individuals with lupus experience a high disease flare burden and as a result engage in preventive and treatment measures.
LFA study, presented at this year's ACR supports multiple imputation (MI) data method.
Trial data from study does show meaningful improvement in the majority of clinical endpoints.
Doctors Petri and Kahlenberg are names the 2018 recipients of the Evelyn V. Hess Award and Mary Betty Stevens Young Investigator Prize.
Exagen Diagnostic, creator of the AVISE® CTD test for lupus, expands portfolio of patented CB-CAPs blood tests.
Awardee research areas underline breadth of field and comprehensive approach to studying lupus.
CEO Sandra C. Raymond responds to announcement of Phase III trial results of anifrolumab.